Global Flow Cytometry Market: Global Industry Analysis and Forecast (2019-2027) – By Technology, Product & Services, Application, End User and Region.

Global Flow Cytometry Market was valued US$ 3.5 Bn in 2019 and is expected to reach US$6.8 Bn by 2027, at a CAGR of 8.66 % during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report

Global Flow Cytometry Market Dynamics:

Flow cytometry is a technology, which is used to measure and analyze multiple characteristics of cells in a sample fluid suspension by a light beam. Increasing market penetration in emerging countries across the globe, development in stem cell research, growing adoption of recombinant DNA technology for antibody production, and the advancement of tandem flow cytometry technologies are projected to boost the growth in the global flow cytometry market during the forecast period. Additionally, the growing prevalence of the disease like cancer and HIV/AIDS, and the growing availability of innovative application-specific flow cytometry products is expected to drive the global flow cytometry market. On the other hand, high costs of flow cytometry instruments and reagents, and lack of awareness about applications of flow cytometry is limiting the growth of the global flow cytometry market during the forecast period. Cell-based flow cytometry is expected to dominate the global flow cytometry market. The dominant position in the market can be attributed to the growing demand for initial diagnosis and increasing awareness relating to associated welfares with cell-based evaluates. The cell-based flow cytometry has widespread applications in many research fields. These evaluations are used in drug discovery for the physical significance of the results. Additionally, it is extensively used in clinical studies with tumor cells in peripheral blood, endothelial cells in blood, tumor stem cells, and hematopoietic progenitor cells. The reagent & consumables segment is expected to grow at a XX % rate of CAGR in the global flow cytometry market. Advancement and commercialization of high-quality application-specific reagents and assays and the increasing requirement of flow cytometry reagents by end users are projected to drive the growth of the reagents and consumables market during the forecast period.

Global Flow Cytometry Market Regional Insights:

North America is expected to share significant growth in the global flow cytometry market followed by the Asia Pacific. The growth in the market is attributed to the presence of supportive government reforms for the expansion of advanced technologies for molecular diagnostics in this region. Additionally, the availability of skilled professionals and increasing awareness about the healthcare level are some of the prominent factors, which are expected to boost the flow cytometry market growth. Furthermore, Asia Pacific is expected to grow at a XX % rate of CAGR in the global flow cytometry market. Increasing expansion of research infrastructure and growing public-private initiative intended towards boosting advance research practices are expected to drive the flow cytometry market in this region. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analysing the market segments and, project the global flow cytometry market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global flow cytometry market. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders in arranging the efforts and investment in the near future to a particular market segment.

Global Flow Cytometry Market, Key Highlights:

• Global Flow Cytometry Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Flow Cytometry Market • Global Flow Cytometry Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Flow Cytometry Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Flow Cytometry Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Flow Cytometry Market are also profiled. The report has considered the base year of 2019 and past four years trend. 2020 figures are at actuals, however due to different dynamics of year 2020, market forecast is not only dependent upon 2020, but on the basis of 2016-2020.

Scope of the Report for Global Flow Cytometry Market: Inquire before buying

Global Flow Cytometry Market, By Technology

• Cell-Based • Bead-Based

Global Flow Cytometry Market, By Product & Service

• Instruments • Reagent & consumables • Software • Accessories • Services

Global Flow Cytometry Market, By Application

• Research o Pharmaceutical  Drug discovery  Stem cells  In vitro toxicity o Apoptosis o Cell sorting o Cell cycle analysis o Immunology o Cell viability • Industrial • Clinical o Cancer o Organ transplantation o Immunodeficiency o Hematologys

Global Flow Cytometry Market, By End User

• Academic and Research Institutes • Hospitals & Clinical Testing Laboratories • Pharmaceutical & Biotechnology

Global Flow Cytometry Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Global Flow Cytometry Market, Key player

• Agilent Technologies • Apogee Flow Systems • BD • BioMérieux SA • Bio-Rad Laboratories, Inc. • Cytonome/ST, LLC • Enzo Life Sciences, Inc. • Luminex Corporation. • Merck KGaA • Miltenyi Biotec • Sony Biotechnology Inc. • Stratedigm, Inc. • Sysmex Partec • Thermo Fisher Scientific • Beckman Coulter, Inc. • Becton • Dickinson and Company • Enzo Life Science, Inc. • Stratedigm, Inc. • Cytek Biosciences • Danaher Corporation

Global Flow Cytometry Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Flow Cytometry Market Size, by Market Value (US$ Bn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Global Flow Cytometry Market Industry Trends 4.8. Global Flow Cytometry Market Global Flow Cytometry Market 5. Supply Side and Demand Side Indicators 6. Global Flow Cytometry Market Analysis and Forecast 6.1. Global Flow Cytometry Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Flow Cytometry Market Analysis and Forecast, by Technology 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Flow Cytometry Market Value Share Analysis, by Technology 7.4. Global Flow Cytometry Market Size (US$ Bn) Forecast, by Technology 7.5. Global Flow Cytometry Market Analysis, by Technology 7.6. Global Flow Cytometry Market Attractiveness Analysis, by Technology 8. Global Flow Cytometry Market Analysis and Forecast, by Product & Service 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Flow Cytometry Market Value Share Analysis, by Product & Service 8.4. Global Flow Cytometry Market Size (US$ Bn) Forecast, by Product & Service 8.5. Global Flow Cytometry Market Analysis, by Product & Service 8.6. Global Flow Cytometry Market Attractiveness Analysis, by Product & Service 9. Global Flow Cytometry Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Flow Cytometry Market Value Share Analysis, by End User 9.4. Global Flow Cytometry Market Size (US$ Bn) Forecast, by End User 9.5. Global Flow Cytometry Market Analysis, by End User 9.6. Global Flow Cytometry Market Attractiveness Analysis, by End User 10. Global Flow Cytometry Market Analysis and Forecast, by Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Flow Cytometry Market Value Share Analysis, by Application 10.4. Global Flow Cytometry Market Size (US$ Bn) Forecast, by Application 10.5. Global Flow Cytometry Market Analysis, by Application 10.6. Global Flow Cytometry Market Attractiveness Analysis, by Application 11. Global Flow Cytometry Market Analysis, by Region 11.1. Global Flow Cytometry Market Value Share Analysis, by Region 11.2. Global Flow Cytometry Market Size (US$ Bn) Forecast, by Region 11.3. Global Flow Cytometry Market Attractiveness Analysis, by Region 12. North America Flow Cytometry Market Analysis 12.1. Key Findings 12.2. North America Flow Cytometry Market Overview 12.3. North America Flow Cytometry Market Value Share Analysis, by Technology 12.4. North America Flow Cytometry Market Forecast, by Technology 12.4.1. Cell-Based 12.4.2. Bead-Based 12.5. North America Flow Cytometry Market Value Share Analysis, by Product & Service 12.6. North America Flow Cytometry Market Forecast, by Product & Service 12.6.1. Instruments 12.6.2. Reagent & consumables 12.7. North America Flow Cytometry Market Value Share Analysis, by End User 12.8. North America Flow Cytometry Market Forecast, by End User 12.8.1. Academic and Research Institutes 12.8.2. Hospitals & Clinical Testing Laboratories 12.8.3. Pharmaceutical & Biotechnology 12.9. North America Flow Cytometry Market Value Share Analysis, by Application 12.10. North America Flow Cytometry Market Forecast, by Application 12.10.1. Research 12.10.1.1. Pharmaceutical 12.10.1.1.1. Drug discovery 12.10.1.1.2. Stem cells 12.10.1.1.3. In vitro toxicity 12.10.1.2. Apoptosis 12.10.1.3. Cell sorting 12.10.1.4. Cell cycle analysis 12.10.1.5. Immunology 12.10.1.6. Cell viability 12.10.2. Industrial 12.10.3. Clinical 12.10.3.1. Cancer 12.10.3.2. Organ transplantation 12.10.3.3. Immunodeficiency 12.10.3.4. Hematologys 12.11. North America Flow Cytometry Market Value Share Analysis, by Country 12.12. North America Flow Cytometry Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Flow Cytometry Market Analysis, by Country 12.14. U.S. Flow Cytometry Market Forecast, by Technology 12.14.1. Cell-Based 12.14.2. Bead-Based 12.15. U.S. Flow Cytometry Market Forecast, by Product & Service 12.15.1. Instruments 12.15.2. Reagent & consumables 12.16. U.S. Flow Cytometry Market Forecast, by End User 12.16.1. Academic and Research Institutes 12.16.2. Hospitals & Clinical Testing Laboratories 12.16.3. Pharmaceutical & Biotechnology 12.17. U.S. Flow Cytometry Market Forecast, by Application 12.17.1. Research 12.17.1.1. Pharmaceutical 12.17.1.1.1. Drug discovery 12.17.1.1.2. Stem cells 12.17.1.1.3. In vitro toxicity 12.17.1.2. Apoptosis 12.17.1.3. Cell sorting 12.17.1.4. Cell cycle analysis 12.17.1.5. Immunology 12.17.1.6. Cell viability 12.17.2. Industrial 12.17.3. Clinical 12.17.3.1. Cancer 12.17.3.2. Organ transplantation 12.17.3.3. Immunodeficiency 12.17.3.4. Hematologys 12.18. Canada Flow Cytometry Market Forecast, by Technology 12.18.1. Cell-Based 12.18.2. Bead-Based 12.19. Canada Flow Cytometry Market Forecast, by Product & Service 12.19.1. Instruments 12.19.2. Reagent & consumables 12.19.3. Software 12.19.4. Accessories 12.19.5. Services 12.20. Canada Flow Cytometry Market Forecast, by End User 12.20.1. Academic and Research Institutes 12.20.2. Hospitals & Clinical Testing Laboratories 12.20.3. Pharmaceutical & Biotechnology 12.21. Canada Flow Cytometry Market Forecast, by Application 12.21.1. Research 12.21.1.1. Pharmaceutical 12.21.1.1.1. Drug discovery 12.21.1.1.2. Stem cells 12.21.1.1.3. In vitro toxicity 12.21.1.2. Apoptosis 12.21.1.3. Cell sorting 12.21.1.4. Cell cycle analysis 12.21.1.5. Immunology 12.21.1.6. Cell viability 12.21.2. Industrial 12.21.3. Clinical 12.21.3.1. Cancer 12.21.3.2. Organ transplantation 12.21.3.3. Immunodeficiency 12.21.3.4. Hematologys 12.22. North America Flow Cytometry Market Attractiveness Analysis 12.22.1. By Technology 12.22.2. By Product & Service 12.22.3. By End User 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Flow Cytometry Market Analysis 13.1. Key Findings 13.2. Europe Flow Cytometry Market Overview 13.3. Europe Flow Cytometry Market Value Share Analysis, by Technology 13.4. Europe Flow Cytometry Market Forecast, by Technology 13.4.1. Cell-Based 13.4.2. Bead-Based 13.5. Europe Flow Cytometry Market Value Share Analysis, by Product & Service 13.6. Europe Flow Cytometry Market Forecast, by Product & Service 13.6.1. Instruments 13.6.2. Reagent & consumables 13.6.3. Software 13.6.4. Accessories 13.6.5. Services 13.7. Europe Flow Cytometry Market Value Share Analysis, by End User 13.8. Europe Flow Cytometry Market Forecast, by End User 13.8.1. Academic and Research Institutes 13.8.2. Hospitals & Clinical Testing Laboratories 13.8.3. Pharmaceutical & Biotechnology 13.9. Europe Flow Cytometry Market Value Share Analysis, by Application 13.10. Europe Flow Cytometry Market Forecast, by Application 13.10.1. Research 13.10.1.1. Pharmaceutical 13.10.1.1.1. Drug discovery 13.10.1.1.2. Stem cells 13.10.1.1.3. In vitro toxicity 13.10.1.2. Apoptosis 13.10.1.3. Cell sorting 13.10.1.4. Cell cycle analysis 13.10.1.5. Immunology 13.10.1.6. Cell viability 13.10.2. Industrial 13.10.3. Clinical 13.10.3.1. Cancer 13.10.3.2. Organ transplantation 13.10.3.3. Immunodeficiency 13.10.3.4. Hematologys 13.11. Europe Flow Cytometry Market Value Share Analysis, by Country 13.12. Europe Flow Cytometry Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Flow Cytometry Market Analysis, by Country 13.14. Germany Flow Cytometry Market Forecast, by Technology 13.14.1. Cell-Based 13.14.2. Bead-Based 13.15. Germany Flow Cytometry Market Forecast, by Product & Service 13.15.1. Instruments 13.15.2. Reagent & consumables 13.15.3. Software 13.15.4. Accessories 13.15.5. Services 13.16. Germany Flow Cytometry Market Forecast, by End User 13.16.1. Academic and Research Institutes 13.16.2. Hospitals & Clinical Testing Laboratories 13.16.3. Pharmaceutical & Biotechnology 13.16.4. Germany Research 13.16.4.1. Pharmaceutical 13.16.4.1.1. Drug discovery 13.16.4.1.2. Stem cells 13.16.4.1.3. In vitro toxicity 13.16.4.2. Apoptosis 13.16.4.3. Cell sorting 13.16.4.4. Cell cycle analysis 13.16.4.5. Immunology 13.16.4.6. Cell viability 13.16.5. Industrial 13.16.6. Clinical 13.16.6.1. Cancer 13.16.6.2. Organ transplantation 13.16.6.3. Immunodeficiency 13.16.6.4. Hematologys 13.17. U.K. Flow Cytometry Market Forecast, by Technology 13.17.1. Cell-Based 13.17.2. Bead-Based 13.18. U.K. Flow Cytometry Market Forecast, by Product & Service 13.18.1. Instruments 13.18.2. Reagent & consumables 13.18.3. Software 13.18.4. Accessories 13.18.5. Services 13.19. U.K. Flow Cytometry Market Forecast, by End User 13.19.1. Academic and Research Institutes 13.19.2. Hospitals & Clinical Testing Laboratories 13.19.3. Pharmaceutical & Biotechnology 13.20. U.K. Flow Cytometry Market Forecast, by Application 13.20.1. Research 13.20.1.1. Pharmaceutical 13.20.1.1.1. Drug discovery 13.20.1.1.2. Stem cells 13.20.1.1.3. In vitro toxicity 13.20.1.2. Apoptosis 13.20.1.3. Cell sorting 13.20.1.4. Cell cycle analysis 13.20.1.5. Immunology 13.20.1.6. Cell viability 13.20.2. Industrial 13.20.3. Clinical 13.20.3.1. Cancer 13.20.3.2. Organ transplantation 13.20.3.3. Immunodeficiency 13.20.3.4. Hematologys 13.21. France Flow Cytometry Market Forecast, by Technology 13.21.1. Cell-Based 13.21.2. Bead-Based 13.22. France Flow Cytometry Market Forecast, by Product & Service 13.22.1. Instruments 13.22.2. Reagent & consumables 13.22.3. Software 13.22.4. Accessories 13.22.5. Services 13.23. France Flow Cytometry Market Forecast, by End User 13.23.1. Academic and Research Institutes 13.23.2. Hospitals & Clinical Testing Laboratories 13.23.3. Pharmaceutical & Biotechnology 13.24. France Flow Cytometry Market Forecast, by Application 13.24.1. Research 13.24.1.1. Pharmaceutical 13.24.1.1.1. Drug discovery 13.24.1.1.2. Stem cells 13.24.1.1.3. In vitro toxicity 13.24.1.2. Apoptosis 13.24.1.3. Cell sorting 13.24.1.4. Cell cycle analysis 13.24.1.5. Immunology 13.24.1.6. Cell viability 13.24.2. Industrial 13.24.3. Clinical 13.24.3.1. Cancer 13.24.3.2. Organ transplantation 13.24.3.3. Immunodeficiency 13.24.3.4. Hematologys 13.25. Italy Flow Cytometry Market Forecast, by Technology 13.25.1. Cell-Based 13.25.2. Bead-Based 13.26. Italy Flow Cytometry Market Forecast, by Product & Service 13.26.1. Instruments 13.26.2. Reagent & consumables 13.26.3. Software 13.26.4. Accessories 13.26.5. Services 13.27. Italy Flow Cytometry Market Forecast, by End User 13.27.1. Academic and Research Institutes 13.27.2. Hospitals & Clinical Testing Laboratories 13.27.3. Pharmaceutical & Biotechnology 13.28. Italy Flow Cytometry Market Forecast, by Application 13.28.1. Research 13.28.1.1. Pharmaceutical 13.28.1.1.1. Drug discovery 13.28.1.1.2. Stem cells 13.28.1.1.3. In vitro toxicity 13.28.1.2. Apoptosis 13.28.1.3. Cell sorting 13.28.1.4. Cell cycle analysis 13.28.1.5. Immunology 13.28.1.6. Cell viability 13.28.2. Industrial 13.28.3. Clinical 13.28.3.1. Cancer 13.28.3.2. Organ transplantation 13.28.3.3. Immunodeficiency 13.28.3.4. Hematologys 13.29. Spain Flow Cytometry Market Forecast, by Technology 13.29.1. Cell-Based 13.29.2. Bead-Based 13.30. Spain Flow Cytometry Market Forecast, by Product & Service 13.30.1. Instruments 13.30.2. Reagent & consumables 13.30.3. Software 13.30.4. Accessories 13.30.5. Services 13.31. Spain Flow Cytometry Market Forecast, by End User 13.31.1. Academic and Research Institutes 13.31.2. Hospitals & Clinical Testing Laboratories 13.31.3. Pharmaceutical & Biotechnology 13.32. Spain Flow Cytometry Market Forecast, by Application 13.32.1. Research 13.32.1.1. Pharmaceutical 13.32.1.1.1. Drug discovery 13.32.1.1.2. Stem cells 13.32.1.1.3. In vitro toxicity 13.32.1.2. Apoptosis 13.32.1.3. Cell sorting 13.32.1.4. Cell cycle analysis 13.32.1.5. Immunology 13.32.1.6. Cell viability 13.32.2. Industrial 13.32.3. Clinical 13.32.3.1. Cancer 13.32.3.2. Organ transplantation 13.32.3.3. Immunodeficiency 13.32.3.4. Hematologys 13.33. Rest of Europe Flow Cytometry Market Forecast, by Technology 13.33.1. Cell-Based 13.33.2. Bead-Based 13.34. Rest of Europe Flow Cytometry Market Forecast, by Product & Service 13.34.1. Instruments 13.34.2. Reagent & consumables 13.34.3. Software 13.34.4. Accessories 13.34.5. Services 13.35. Rest of Europe Flow Cytometry Market Forecast, by End User 13.35.1. Academic and Research Institutes 13.35.2. Hospitals & Clinical Testing Laboratories 13.35.3. Pharmaceutical & Biotechnology 13.36. Rest Of Europe Flow Cytometry Market Forecast, by Application 13.36.1. Research 13.36.1.1. Pharmaceutical 13.36.1.1.1. Drug discovery 13.36.1.1.2. Stem cells 13.36.1.1.3. In vitro toxicity 13.36.1.2. Apoptosis 13.36.1.3. Cell sorting 13.36.1.4. Cell cycle analysis 13.36.1.5. Immunology 13.36.1.6. Cell viability 13.36.2. Industrial 13.36.3. Clinical 13.36.3.1. Cancer 13.36.3.2. Organ transplantation 13.36.3.3. Immunodeficiency 13.36.3.4. Hematologys 13.37. Europe Flow Cytometry Market Attractiveness Analysis 13.37.1. By Technology 13.37.2. By Product & Service 13.37.3. By End User 13.37.4. By Application 13.38. PEST Analysis 13.39. Key Trends 13.40. Key Developments 14. Asia Pacific Flow Cytometry Market Analysis 14.1. Key Findings 14.2. Asia Pacific Flow Cytometry Market Overview 14.3. Asia Pacific Flow Cytometry Market Value Share Analysis, by Technology 14.4. Asia Pacific Flow Cytometry Market Forecast, by Technology 14.4.1. Cell-Based 14.4.2. Bead-Based 14.5. Asia Pacific Flow Cytometry Market Value Share Analysis, by Product & Service 14.6. Asia Pacific Flow Cytometry Market Forecast, by Product & Service 14.6.1. Instruments 14.6.2. Reagent & consumables 14.6.3. Software 14.6.4. Accessories 14.6.5. Services 14.7. Asia Pacific Flow Cytometry Market Value Share Analysis, by End User 14.8. Asia Pacific Flow Cytometry Market Forecast, by End User 14.8.1. Academic and Research Institutes 14.8.2. Hospitals & Clinical Testing Laboratories 14.8.3. Pharmaceutical & Biotechnology 14.9. Asia Pacific Flow Cytometry Market Value Share Analysis, by Application 14.10. Asia Pacific Flow Cytometry Market Forecast, by Application 14.10.1. Research 14.10.1.1. Pharmaceutical 14.10.1.1.1. Drug discovery 14.10.1.1.2. Stem cells 14.10.1.1.3. In vitro toxicity 14.10.1.2. Apoptosis 14.10.1.3. Cell sorting 14.10.1.4. Cell cycle analysis 14.10.1.5. Immunology 14.10.1.6. Cell viability 14.10.2. Industrial 14.10.3. Clinical 14.10.3.1. Cancer 14.10.3.2. Organ transplantation 14.10.3.3. Immunodeficiency 14.10.3.4. Hematologys 14.11. Asia Pacific Flow Cytometry Market Value Share Analysis, by Country 14.12. Asia Pacific Flow Cytometry Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Flow Cytometry Market Analysis, by Country 14.14. China Flow Cytometry Market Forecast, by Technology 14.14.1. Cell-Based 14.14.2. Bead-Based 14.15. China Flow Cytometry Market Forecast, by Product & Service 14.15.1. Instruments 14.15.2. Reagent & consumables 14.15.3. Software 14.15.4. Accessories 14.15.5. Services 14.16. China Flow Cytometry Market Forecast, by End User 14.16.1. Academic and Research Institutes 14.16.2. Hospitals & Clinical Testing Laboratories 14.16.3. Pharmaceutical & Biotechnology 14.17. China Flow Cytometry Market Forecast, by Application 14.17.1. Research 14.17.1.1. Pharmaceutical 14.17.1.1.1. Drug discovery 14.17.1.1.2. Stem cells 14.17.1.1.3. In vitro toxicity 14.17.1.2. Apoptosis 14.17.1.3. Cell sorting 14.17.1.4. Cell cycle analysis 14.17.1.5. Immunology 14.17.1.6. Cell viability 14.17.2. Industrial 14.17.3. Clinical 14.17.3.1. Cancer 14.17.3.2. Organ transplantation 14.17.3.3. Immunodeficiency 14.17.3.4. Hematologys 14.18. India Flow Cytometry Market Forecast, by Technology 14.18.1. Cell-Based 14.18.2. Bead-Based 14.19. India Flow Cytometry Market Forecast, by Product & Service 14.19.1. Instruments 14.19.2. Reagent & consumables 14.19.3. Software 14.19.4. Accessories 14.19.5. Services 14.20. India Flow Cytometry Market Forecast, by End User 14.20.1. Academic and Research Institutes 14.20.2. Hospitals & Clinical Testing Laboratories 14.20.3. Pharmaceutical & Biotechnology 14.21. India Flow Cytometry Market Forecast, by Application 14.21.1. Research 14.21.1.1. Pharmaceutical 14.21.1.1.1. Drug discovery 14.21.1.1.2. Stem cells 14.21.1.1.3. In vitro toxicity 14.21.1.2. Apoptosis 14.21.1.3. Cell sorting 14.21.1.4. Cell cycle analysis 14.21.1.5. Immunology 14.21.1.6. Cell viability 14.21.2. Industrial 14.21.3. Clinical 14.21.3.1. Cancer 14.21.3.2. Organ transplantation 14.21.3.3. Immunodeficiency 14.21.3.4. Hematologys 14.22. Japan Flow Cytometry Market Forecast, by Technology 14.22.1. Cell-Based 14.22.2. Bead-Based 14.23. Japan Flow Cytometry Market Forecast, by Product & Service 14.23.1. Instruments 14.23.2. Reagent & consumables 14.23.3. Software 14.23.4. Accessories 14.23.5. Services 14.24. Japan Flow Cytometry Market Forecast, by End User 14.24.1. Academic and Research Institutes 14.24.2. Hospitals & Clinical Testing Laboratories 14.24.3. Pharmaceutical & Biotechnology 14.25. Japan Flow Cytometry Market Forecast, by Application 14.25.1. Research 14.25.1.1. Pharmaceutical 14.25.1.1.1. Drug discovery 14.25.1.1.2. Stem cells 14.25.1.1.3. In vitro toxicity 14.25.1.2. Apoptosis 14.25.1.3. Cell sorting 14.25.1.4. Cell cycle analysis 14.25.1.5. Immunology 14.25.1.6. Cell viability 14.25.2. Industrial 14.25.3. Clinical 14.25.3.1. Cancer 14.25.3.2. Organ transplantation 14.25.3.3. Immunodeficiency 14.25.3.4. Hematologys 14.26. ASEAN Flow Cytometry Market Forecast, by Technology 14.26.1. Cell-Based 14.26.2. Bead-Based 14.27. ASEAN Flow Cytometry Market Forecast, by Product & Service 14.27.1. Instruments 14.27.2. Reagent & consumables 14.27.3. Software 14.27.4. Accessories 14.27.5. Services 14.28. ASEAN Flow Cytometry Market Forecast, by End User 14.28.1. Academic and Research Institutes 14.28.2. Hospitals & Clinical Testing Laboratories 14.28.3. Pharmaceutical & Biotechnology 14.29. ASEAN Flow Cytometry Market Forecast, by Application 14.29.1. Research 14.29.1.1. Pharmaceutical 14.29.1.1.1. Drug discovery 14.29.1.1.2. Stem cells 14.29.1.1.3. In vitro toxicity 14.29.1.2. Apoptosis 14.29.1.3. Cell sorting 14.29.1.4. Cell cycle analysis 14.29.1.5. Immunology 14.29.1.6. Cell viability 14.29.2. Industrial 14.29.3. Clinical 14.29.3.1. Cancer 14.29.3.2. Organ transplantation 14.29.3.3. Immunodeficiency 14.29.3.4. Hematologys 14.30. Rest of Asia Pacific Flow Cytometry Market Forecast, by Technology 14.30.1. Cell-Based 14.30.2. Bead-Based 14.31. Rest of Asia Pacific Flow Cytometry Market Forecast, by Product & Service 14.31.1. Instruments 14.31.2. Reagent & consumables 14.31.3. Software 14.31.4. Accessories 14.31.5. Services 14.32. Rest of Asia Pacific Flow Cytometry Market Forecast, by End User 14.32.1. Academic and Research Institutes 14.32.2. Hospitals & Clinical Testing Laboratories 14.32.3. Pharmaceutical & Biotechnology 14.33. Rest of Asia Pacific Flow Cytometry Market Forecast, by Application 14.33.1. Research 14.33.1.1. Pharmaceutical 14.33.1.1.1. Drug discovery 14.33.1.1.2. Stem cells 14.33.1.1.3. In vitro toxicity 14.33.1.2. Apoptosis 14.33.1.3. Cell sorting 14.33.1.4. Cell cycle analysis 14.33.1.5. Immunology 14.33.1.6. Cell viability 14.33.2. Industrial 14.33.3. Clinical 14.33.3.1. Cancer 14.33.3.2. Organ transplantation 14.33.3.3. Immunodeficiency 14.33.3.4. Hematologys 14.34. Asia Pacific Flow Cytometry Market Attractiveness Analysis 14.34.1. By Technology 14.34.2. By Product & Service 14.34.3. By End User 14.34.4. By Application 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Flow Cytometry Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Flow Cytometry Market Overview 15.3. Middle East & Africa Flow Cytometry Market Value Share Analysis, by Technology 15.4. Middle East & Africa Flow Cytometry Market Forecast, by Technology 15.4.1. Cell-Based 15.4.2. Bead-Based 15.5. Middle East & Africa Flow Cytometry Market Value Share Analysis, by Product & Service 15.6. Middle East & Africa Flow Cytometry Market Forecast, by Product & Service 15.6.1. Instruments 15.6.2. Reagent & consumables 15.6.3. Software 15.6.4. Accessories 15.6.5. Services 15.7. Middle East & Africa Flow Cytometry Market Value Share Analysis, by End User 15.8. Middle East & Africa Flow Cytometry Market Forecast, by End User 15.8.1. Academic and Research Institutes 15.8.2. Hospitals & Clinical Testing Laboratories 15.8.3. Pharmaceutical & Biotechnology 15.9. Middle East & Africa Flow Cytometry Market Value Share Analysis, by Application 15.10. Middle East & Africa Flow Cytometry Market Forecast, by Application 15.10.1. Research 15.10.1.1. Pharmaceutical 15.10.1.1.1. Drug discovery 15.10.1.1.2. Stem cells 15.10.1.1.3. In vitro toxicity 15.10.1.2. Apoptosis 15.10.1.3. Cell sorting 15.10.1.4. Cell cycle analysis 15.10.1.5. Immunology 15.10.1.6. Cell viability 15.10.2. Industrial 15.10.3. Clinical 15.10.3.1. Cancer 15.10.3.2. Organ transplantation 15.10.3.3. Immunodeficiency 15.10.3.4. Hematologys 15.11. Middle East & Africa Flow Cytometry Market Value Share Analysis, by Country 15.12. Middle East & Africa Flow Cytometry Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Flow Cytometry Market Analysis, by Country 15.14. GCC Flow Cytometry Market Forecast, by Technology 15.14.1. Cell-Based 15.14.2. Bead-Based 15.15. GCC Flow Cytometry Market Forecast, by Product & Service 15.15.1. Instruments 15.15.2. Reagent & consumables 15.15.3. Software 15.15.4. Accessories 15.15.5. Services 15.16. GCC Flow Cytometry Market Forecast, by End User 15.16.1. Academic and Research Institutes 15.16.2. Hospitals & Clinical Testing Laboratories 15.16.3. Pharmaceutical & Biotechnology 15.17. GCC Flow Cytometry Market Forecast, by Application 15.17.1. Research 15.17.1.1. Pharmaceutical 15.17.1.1.1. Drug discovery 15.17.1.1.2. Stem cells 15.17.1.1.3. In vitro toxicity 15.17.1.2. Apoptosis 15.17.1.3. Cell sorting 15.17.1.4. Cell cycle analysis 15.17.1.5. Immunology 15.17.1.6. Cell viability 15.17.2. Industrial 15.17.3. Clinical 15.17.3.1. Cancer 15.17.3.2. Organ transplantation 15.17.3.3. Immunodeficiency 15.17.3.4. Hematologys 15.18. South Africa Flow Cytometry Market Forecast, by Technology 15.18.1. Cell-Based 15.18.2. Bead-Based 15.19. South Africa Flow Cytometry Market Forecast, by Product & Service 15.19.1. Instruments 15.19.2. Reagent & consumables 15.19.3. Software 15.19.4. Accessories 15.19.5. Services 15.20. South Africa Flow Cytometry Market Forecast, by End User 15.20.1. Academic and Research Institutes 15.20.2. Hospitals & Clinical Testing Laboratories 15.20.3. Pharmaceutical & Biotechnology 15.21. South Africa Flow Cytometry Market Forecast, by Application 15.21.1. Research 15.21.1.1. Pharmaceutical 15.21.1.1.1. Drug discovery 15.21.1.1.2. Stem cells 15.21.1.1.3. In vitro toxicity 15.21.1.2. Apoptosis 15.21.1.3. Cell sorting 15.21.1.4. Cell cycle analysis 15.21.1.5. Immunology 15.21.1.6. Cell viability 15.21.2. Industrial 15.21.3. Clinical 15.21.3.1. Cancer 15.21.3.2. Organ transplantation 15.21.3.3. Immunodeficiency 15.21.3.4. Hematologys 15.22. Rest of Middle East & Africa Flow Cytometry Market Forecast, by Technology 15.22.1. Cell-Based 15.22.2. Bead-Based 15.23. Rest of Middle East & Africa Flow Cytometry Market Forecast, by Product & Service 15.23.1. Instruments 15.23.2. Reagent & consumables 15.23.3. Software 15.23.4. Accessories 15.23.5. Services 15.24. Rest of Middle East & Africa Flow Cytometry Market Forecast, by End User 15.24.1. Academic and Research Institutes 15.24.2. Hospitals & Clinical Testing Laboratories 15.24.3. Pharmaceutical & Biotechnology 15.25. Rest of Middle East & Africa Flow Cytometry Market Forecast, by Application 15.25.1. Research 15.25.1.1. Pharmaceutical 15.25.1.1.1. Drug discovery 15.25.1.1.2. Stem cells 15.25.1.1.3. In vitro toxicity 15.25.1.2. Apoptosis 15.25.1.3. Cell sorting 15.25.1.4. Cell cycle analysis 15.25.1.5. Immunology 15.25.1.6. Cell viability 15.25.2. Industrial 15.25.3. Clinical 15.25.3.1. Cancer 15.25.3.2. Organ transplantation 15.25.3.3. Immunodeficiency 15.25.3.4. Hematologys 15.26. Middle East & Africa Flow Cytometry Market Attractiveness Analysis 15.26.1. By Technology 15.26.2. By Product & Service 15.26.3. By End User 15.26.4. By Application 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Flow Cytometry Market Analysis 16.1. Key Findings 16.2. South America Flow Cytometry Market Overview 16.3. South America Flow Cytometry Market Value Share Analysis, by Technology 16.4. South America Flow Cytometry Market Forecast, by Technology 16.4.1. Cell-Based 16.4.2. Bead-Based 16.5. South America Flow Cytometry Market Value Share Analysis, by Product & Service 16.6. South America Flow Cytometry Market Forecast, by Product & Service 16.6.1. Instruments 16.6.2. Reagent & consumables 16.6.3. Software 16.6.4. Accessories 16.6.5. Services 16.7. South America Flow Cytometry Market Value Share Analysis, by End User 16.8. South America Flow Cytometry Market Forecast, by End User 16.8.1. Academic and Research Institutes 16.8.2. Hospitals & Clinical Testing Laboratories 16.8.3. Pharmaceutical & Biotechnology 16.9. South America Flow Cytometry Market Value Share Analysis, by Application 16.10. South America Flow Cytometry Market Forecast, by Application 16.10.1. Research 16.10.1.1. Pharmaceutical 16.10.1.1.1. Drug discovery 16.10.1.1.2. Stem cells 16.10.1.1.3. In vitro toxicity 16.10.1.2. Apoptosis 16.10.1.3. Cell sorting 16.10.1.4. Cell cycle analysis 16.10.1.5. Immunology 16.10.1.6. Cell viability 16.10.2. Industrial 16.10.3. Clinical 16.10.3.1. Cancer 16.10.3.2. Organ transplantation 16.10.3.3. Immunodeficiency 16.10.3.4. Hematologys 16.11. South America Flow Cytometry Market Value Share Analysis, by Country 16.12. South America Flow Cytometry Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Flow Cytometry Market Analysis, by Country 16.14. Brazil Flow Cytometry Market Forecast, by Technology 16.14.1. Cell-Based 16.14.2. Bead-Based 16.15. Brazil Flow Cytometry Market Forecast, by Product & Service 16.15.1. Instruments 16.15.2. Reagent & consumables 16.15.3. Software 16.15.4. Accessories 16.15.5. Services 16.16. Brazil Flow Cytometry Market Forecast, by End User 16.16.1. Academic and Research Institutes 16.16.2. Hospitals & Clinical Testing Laboratories 16.16.3. Pharmaceutical & Biotechnology 16.17. Brazil Flow Cytometry Market Forecast, by Application 16.17.1. Research 16.17.1.1. Pharmaceutical 16.17.1.1.1. Drug discovery 16.17.1.1.2. Stem cells 16.17.1.1.3. In vitro toxicity 16.17.1.2. Apoptosis 16.17.1.3. Cell sorting 16.17.1.4. Cell cycle analysis 16.17.1.5. Immunology 16.17.1.6. Cell viability 16.17.2. Industrial 16.17.3. Clinical 16.17.3.1. Cancer 16.17.3.2. Organ transplantation 16.17.3.3. Immunodeficiency 16.17.3.4. Hematologys 16.18. Mexico Flow Cytometry Market Forecast, by Technology 16.18.1. Cell-Based 16.18.2. Bead-Based 16.19. Mexico Flow Cytometry Market Forecast, by Product & Service 16.19.1. Instruments 16.19.2. Reagent & consumables 16.19.3. Software 16.19.4. Accessories 16.19.5. Services 16.20. Mexico Flow Cytometry Market Forecast, by End User 16.20.1. Academic and Research Institutes 16.20.2. Hospitals & Clinical Testing Laboratories 16.20.3. Pharmaceutical & Biotechnology 16.21. Mexico Flow Cytometry Market Forecast, by Application 16.21.1. Research 16.21.1.1. Pharmaceutical 16.21.1.1.1. Drug discovery 16.21.1.1.2. Stem cells 16.21.1.1.3. In vitro toxicity 16.21.1.2. Apoptosis 16.21.1.3. Cell sorting 16.21.1.4. Cell cycle analysis 16.21.1.5. Immunology 16.21.1.6. Cell viability 16.21.2. Industrial 16.21.3. Clinical 16.21.3.1. Cancer 16.21.3.2. Organ transplantation 16.21.3.3. Immunodeficiency 16.21.3.4. Hematologys 16.22. Rest of South America Flow Cytometry Market Forecast, by Technology 16.22.1. Cell-Based 16.22.2. Bead-Based 16.23. Rest of South America Flow Cytometry Market Forecast, by Product & Service 16.23.1. Instruments 16.23.2. Reagent & consumables 16.23.3. Software 16.23.4. Accessories 16.23.5. Services 16.24. Rest of South America Flow Cytometry Market Forecast, by End User 16.24.1. Academic and Research Institutes 16.24.2. Hospitals & Clinical Testing Laboratories 16.24.3. Pharmaceutical & Biotechnology 16.25. Rest of South America Flow Cytometry Market Forecast, by Application 16.25.1. Research 16.25.1.1. Pharmaceutical 16.25.1.1.1. Drug discovery 16.25.1.1.2. Stem cells 16.25.1.1.3. In vitro toxicity 16.25.1.2. Apoptosis 16.25.1.3. Cell sorting 16.25.1.4. Cell cycle analysis 16.25.1.5. Immunology 16.25.1.6. Cell viability 16.25.2. Industrial 16.25.3. Clinical 16.25.3.1. Cancer 16.25.3.2. Organ transplantation 16.25.3.3. Immunodeficiency 16.25.3.4. Hematologys 16.26. South America Flow Cytometry Market Attractiveness Analysis 16.26.1. By Technology 16.26.2. By Product & Service 16.26.3. By End User 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Agilent Technologies 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Company Footprint 17.3.2. Apogee Flow Systems 17.3.3. BD 17.3.4. BioMérieux SA 17.3.5. Bio-Rad Laboratories, Inc. 17.3.6. Cytonome/ST, LLC 17.3.7. Enzo Life Sciences, Inc. 17.3.8. Luminex Corporation. 17.3.9. Merck KGaA 17.3.10. Miltenyi Biotec 17.3.11. Sony Biotechnology Inc. 17.3.12. Stratedigm, Inc. 17.3.13. Sysmex Partec 17.3.14. Thermo Fisher Scientific 17.3.15. Beckman Coulter, Inc. 17.3.16. Becton 17.3.17. Dickinson and Company 17.3.18. Enzo Life Science, Inc. 17.3.19. Stratedigm, Inc. 17.3.20. Cytek Biosciences 17.3.21. Danaher Corporation 18. Primary Key Insights

About This Report

Report ID29653
Category Healthcare
Published DateMay 2019
Updated DateNov 2020
Contact Us